Mesenchymal stem cells prevent the blood pressure increase in renovascular hypertension (2011)
- Authors:
- Autor USP: CÂMARA, NIELS OLSEN SARAIVA - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2011
- Source:
- Título do periódico: FASEB Journal
- ISSN: 1521-6616
- Volume/Número/Paginação/Ano: v. 25, Supplement, 2011
- Conference titles: Experimental Biology
-
ABNT
SALES, Elizabeth B. Oliveira et al. Mesenchymal stem cells prevent the blood pressure increase in renovascular hypertension. FASEB Journal. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 27 abr. 2024. , 2011 -
APA
Sales, E. B. O., Maquigussa, E., Semedo, P., Câmara, N. O. S., Bergamaschi, C. T., Boim, M. A., & Campos, R. R. (2011). Mesenchymal stem cells prevent the blood pressure increase in renovascular hypertension. FASEB Journal. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Sales EBO, Maquigussa E, Semedo P, Câmara NOS, Bergamaschi CT, Boim MA, Campos RR. Mesenchymal stem cells prevent the blood pressure increase in renovascular hypertension. FASEB Journal. 2011 ; 25[citado 2024 abr. 27 ] -
Vancouver
Sales EBO, Maquigussa E, Semedo P, Câmara NOS, Bergamaschi CT, Boim MA, Campos RR. Mesenchymal stem cells prevent the blood pressure increase in renovascular hypertension. FASEB Journal. 2011 ; 25[citado 2024 abr. 27 ] - Pioglitazone limits cyclosporine nephrotoxicity in rats
- The role of toll-like receptor 4 in cisplatin-induced renal injury
- A role for HO-1 in the renal function impairment inrapamucin-treated animals submitted to ischemic and reperfusion injury (IRI)
- Renal transplantation outcomes: a comparative analysis between elderly and younger recipients
- High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection
- Detection of Vbeta11 positive cells inside renal allograft during acute rejection
- PPARg agonists on renal ischemia/reperfusion injury
- Role of PPARy-activation in established chronic cyclosporine nephrotoxicity
- Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome
- Imunobiologia do transplante
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas